The 2025 ISPE Annual Meeting & Expo, set to be held from 26–29 October in Charlotte, North Carolina, USA, and virtually, offers over 60 hours of educational content, a robust exhibit hall featuring more than 200 exhibitors, and the opportunity to learn from more than 160 speakers across key areas in pharmaceutical science and manufacturing. Attendees will also enjoy networking events including the Facility of the Year Awards (FOYA) Banquet and Awards Celebration, Welcome Reception, and Tuesday Night Celebration.
Transforming Industry Culture Through Pharma 4.0
Pharma 4.0 integrates digital tools and data systems into pharmaceutical operations to improve efficiency and adaptability. At its core, it fosters a mindset of continuous improvement and innovation. It enables organizations to stay resilient and forward-looking in an increasingly complex regulatory and technological environment.
Through its active Pharma 4.0 Community of Practice, ISPE helps the industry implement practical, regulatory-aligned strategies that support innovation and compliance, which ultimately benefits patients. This collaborative knowledge-sharing network ensures that companies of all sizes can engage in the digital transformation journey.
Spotlight Sessions Across Various Tracks on Regulatory and Quality Topics
Biologics manufacturing is rapidly evolving. On Monday, Wei Huang of Henlius Biopharmaceutical Ltd., will present “Novel Technology Applied in Biologics Manufacturing,” highlighting advances in continuous bioprocessing, real-time analytics, and AI integration—technologies that are reshaping how biologics are produced to ensure scalability, quality, and affordability.
Artificial intelligence (AI) and machine learning offer great promise in regulated environments. On Monday, Afrah Mujeeb of Access Vascular Inc. will explore how global agencies like the US Food and Drug Administration (US FDA), European Medicines Agency (EMA), and International Council for Harmonisation of Technical Requirements for Human Use (ICH) are guiding the ethical adoption of AI. His presentation addresses compliance frameworks, harmonization, and implementation tools. Attendees will gain practical insights into how AI can be implemented safely while enhancing regulatory performance.
On Tuesday, Brandi Stockton of The Triality Group, LLC, and Eric Staib of Syneos Health will provide a roadmap for integrating AI into GxP environments. Her session offers structure and confidence for professionals looking to innovate while maintaining safety and compliance. She will address emerging best practices and how companies can build governance frameworks that support AI innovation responsibly.
Enabling Sustainability Through Innovation
Sustainability is now a strategic imperative. Melanee Short of Sanofi will demonstrate how gamification and partnerships can drive environmental impact. Her session provides insights on how to embed sustainability into operations and long-term strategy, while also influencing a cultural shift toward greener practices within pharmaceutical organizations.
Addressing Challenges in ATMP Manufacturing
Advanced Therapy Medicinal Products (ATMPs) offer new possibilities but bring complex manufacturing challenges. On Tuesday, George Todorov and Stephen Lane of IPS will present “Simulation-Driven Solutions for Cell Therapy Manufacturing Ramp-Up,” offering tools to scale therapies efficiently while ensuring quality. Their session bridges digital simulation and real-world application, helping companies prepare for the increasing demand of patient-specific therapies.
Five Tracks, One Shared Vision
This year’s program structure reflects the breadth of Pharma 4.0. The five tracks include:
- ATMPs: Manufacturing complexities and harmonization
- Digital Transformation: AI, machine learning, and data integrity
- Manufacturing and Operational Excellence: Process design, change management, and workforce development
- Regulatory, Compliance, and Quality: Global convergence and risk-based approaches
- Sustainability and Supply Chain Resiliency: Environmental responsibility and AI-driven resilience
Each track supports the Pharma 4.0 mission to modernize processes and improve patient outcomes. Whether attending in person or virtually, participants can expect high-value insights and practical frameworks they can bring back to their organizations.
The sessions highlighted above reflect the diversity of content offered across the conference. They span multiple tracks, and attendees are encouraged to explore the full agenda for additional opportunities of interest.
Collaborative Engagement: Industry-Regulatory Town Hall
The Global Regulatory Town Hall invites an open dialogue between regulators and industry leaders. Participants will explore AI, modeling capabilities, and harmonization. This session fosters direct engagement and collaborative vision-building.
Attendees will have the opportunity to raise questions, exchange views with senior leaders, and contribute to shaping a globally aligned regulatory environment. This dialogue is especially relevant in a landscape where data integrity, digital validation, and AI are becoming central themes in regulatory science.
Moving Forward, Together
Pharma 4.0 is not only about technology: it's about people. It requires cross-functional collaboration, visionary thinking, and a commitment to ethical progress. Everyone’s voice matters—whether an attendee is new to the field or experienced. As organizations continue to evolve, professionals who understand and can lead digital transformation efforts will be increasingly essential.
Advancing Patient-Centered Innovation
At the core of Pharma 4.0 is a shared purpose: enhancing patient lives. By aligning innovation with regulatory rigor and operational excellence, we can deliver therapies more quickly, reliably, and safely. The integration of digital systems must ultimately serve this mission—to expand access to effective treatments and improve global health outcomes.
The Regulatory, Compliance, and Quality track at the 2025 ISPE Annual Meeting & Expo provides the tools, insights, and peer connections needed to lead in this transformative era.
Explore the full agenda and learn more.
